Back to today’s briefing

Story perspectives

AI Models Transform Genetic Risk Assessment and Atrial Fibrillation Treatment

9/4/2025

29 3 Full Breakdown

Summary

Story summary

Mount Sinai researchers created an AI model to evaluate genetic mutations' disease risk, utilizing electronic health records and machine learning. This approach provides a detailed assessment of genetic risk, surpassing binary classifications.
A separate AI model for atrial fibrillation (AF) patients suggests personalized treatment, potentially minimizing unnecessary anticoagulant prescriptions by considering stroke and bleeding risks.

1 of 1

Story summary

Mount Sinai researchers created an AI model to evaluate genetic mutations' disease risk, utilizing electronic health records and machine learning. This approach provides a detailed assessment of genetic risk, surpassing binary classifications.
A separate AI model for atrial fibrillation (AF) patients suggests personalized treatment, potentially minimizing unnecessary anticoagulant prescriptions by considering stroke and bleeding risks.